Literature DB >> 25966425

Clinical presentation, risk factors and staging systems of cholangiocarcinoma.

Ruben R Plentz1, Nisar P Malek2.   

Abstract

Cholangiocarcinoma (CCA) is the second most common primary liver tumour. Intra-hepatic CCA develops within the liver parenchyma while extrahepatic CCA involves the biliary tree within the hepatoduodenal ligament. Hilar CCA are also called Klatskin tumour. The CCA incidence has increased worldwide over the last years, but there are also geographic differences, with focus in Asian countries. Known risk factors are primary sclerosing cholangitis (PSC), hepatolithiasis, Caroli's disease, hepatitis B and C infection, liver flukes, cirrhosis, diabetes, obesity, alcohol consumption and probably tobacco smoking. Patients with early CCA have only little discomfort, but can later show episodes with jaundice and other non-specific tumour symptoms. For the staging of the disease different classifications are available, which consider various factors like tumour size, location, regional lymph nodes, metastasis, vascular involvement and tumour marker.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Risks; Staging systems; Symptoms

Mesh:

Year:  2015        PMID: 25966425     DOI: 10.1016/j.bpg.2015.02.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  23 in total

Review 1.  Imaging of Cholangiocarcinoma.

Authors:  Susann-Cathrin Olthof; Ahmed Othman; Stephan Clasen; Christina Schraml; Konstantin Nikolaou; Malte Bongers
Journal:  Visc Med       Date:  2016-12-06

2.  Impact of adjuvant chemoradiation on survival in patients with resectable cholangiocarcinoma.

Authors:  Laura L Dover; Robert A Oster; Andrew M McDonald; Derek A DuBay; Thomas N Wang; Rojymon Jacob
Journal:  HPB (Oxford)       Date:  2016-08-16       Impact factor: 3.647

3.  Surgical Management of Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Impact of Lymphadenectomy on Peri-Operative Outcomes.

Authors:  Fabio Bagante; Gaya Spolverato; Matthew Weiss; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Olivier Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Andrea Ruzzenente; Timothy M Pawlik
Journal:  World J Surg       Date:  2018-08       Impact factor: 3.352

4.  Epidemiology and Risk Factors of Cholangiocarcinoma.

Authors:  Martha M Kirstein; Arndt Vogel
Journal:  Visc Med       Date:  2016-12-01

5.  Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping.

Authors:  Yao Xiao; Baoluhe Zhang; Jordan M Cloyd; Laura Alaimo; Gang Xu; Shunda Du; Yilei Mao; Timothy M Pawlik
Journal:  Cancers (Basel)       Date:  2022-07-05       Impact factor: 6.575

Review 6.  Hepatolithiasis and intrahepatic cholangiocarcinoma: A review.

Authors:  Hyo Jung Kim; Jae Seon Kim; Moon Kyung Joo; Beom Jae Lee; Ji Hoon Kim; Jong Eun Yeon; Jong-Jae Park; Kwan Soo Byun; Young-Tae Bak
Journal:  World J Gastroenterol       Date:  2015-12-28       Impact factor: 5.742

7.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

8.  Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.

Authors:  Andrea A Florio; Jacques Ferlay; Ariana Znaor; David Ruggieri; Christian S Alvarez; Mathieu Laversanne; Freddie Bray; Katherine A McGlynn; Jessica L Petrick
Journal:  Cancer       Date:  2020-03-04       Impact factor: 6.921

9.  A significant cancer burden and high mortality of intrahepatic cholangiocarcinoma in Thailand: a nationwide database study.

Authors:  Sombat Treeprasertsuk; Kittiyod Poovorawan; Ngamphol Soonthornworasiri; Roongruedee Chaiteerakij; Kessarin Thanapirom; Pisaln Mairiang; Kookwan Sawadpanich; Kanokwan Sonsiri; Varocha Mahachai; Kamthorn Phaosawasdi
Journal:  BMC Gastroenterol       Date:  2017-01-05       Impact factor: 3.067

Review 10.  New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.

Authors:  Maria Consiglia Bragazzi; Lorenzo Ridola; Samira Safarikia; Sabina Di Matteo; Daniele Costantini; Lorenzo Nevi; Vincenzo Cardinale
Journal:  Ann Gastroenterol       Date:  2017-11-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.